Abbott's next-generation Xience Prime Drug Eluting Stent system gets Japanese ... pharmabiz.com Abbott, a global, broad-based health care company, has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the next-generation Xience Prime Everolimus Eluting Coronary Stent System for the treatment of coronary artery ... Abbott Receives Approval For Xience Prime Everolimus Eluting Stent In Japan Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent ... |
